Business Standard

Wednesday, December 25, 2024 | 11:43 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Vapi firm becomes India's first to take on Abbott in biodegradeable stents

Meril Life Sciences is first Indian firm to get nod for bio-resorbable cardiac scaffold

Department of Pharma consults stakeholders on pricing mechanism for stents
Premium

Sohini Das Ahmedabad
Meril Life Sciences, a medical devices company based out of the nondescript town of Vapi, has emerged as a challenger to multinational giant Abbott in the category of bioresorbable cardiac scaffold (BVS), following the health ministry’s recent approval of its product.

It has developed MeRes100, now recognised as India’s first indigenously made BVS — a naturally dissolving cardiac stent made out of biodegradable material and used for clearing blockages in arteries of the heart. While Meril has developed BVS for both coronary and peripheral arteries, for starters, it has received approval for the coronary variant.

The only other BVS available in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in